Your browser doesn't support javascript.
loading
MYC protein interactors in gene transcription and cancer.
Lourenco, Corey; Resetca, Diana; Redel, Cornelia; Lin, Peter; MacDonald, Alannah S; Ciaccio, Roberto; Kenney, Tristan M G; Wei, Yong; Andrews, David W; Sunnerhagen, Maria; Arrowsmith, Cheryl H; Raught, Brian; Penn, Linda Z.
Afiliação
  • Lourenco C; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Resetca D; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Redel C; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Lin P; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • MacDonald AS; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Ciaccio R; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kenney TMG; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Wei Y; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Andrews DW; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Sunnerhagen M; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Arrowsmith CH; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Raught B; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Penn LZ; Princess Margaret Cancer Centre, Toronto, ON, Canada.
Nat Rev Cancer ; 21(9): 579-591, 2021 09.
Article em En | MEDLINE | ID: mdl-34188192
ABSTRACT
The transcription factor and oncoprotein MYC is a potent driver of many human cancers and can regulate numerous biological activities that contribute to tumorigenesis. How a single transcription factor can regulate such a diverse set of biological programmes is central to the understanding of MYC function in cancer. In this Perspective, we highlight how multiple proteins that interact with MYC enable MYC to regulate several central control points of gene transcription. These include promoter binding, epigenetic modifications, initiation, elongation and post-transcriptional processes. Evidence shows that a combination of multiple protein interactions enables MYC to function as a potent oncoprotein, working together in a 'coalition model', as presented here. Moreover, as MYC depends on its protein interactome for function, we discuss recent research that emphasizes an unprecedented opportunity to target protein interactors to directly impede MYC oncogenesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transcrição Gênica / Proteína Oncogênica p55(v-myc) / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Rev Cancer Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transcrição Gênica / Proteína Oncogênica p55(v-myc) / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Rev Cancer Ano de publicação: 2021 Tipo de documento: Article